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The causes and frequency of acute paralysis and res-
piratory failure with West Nile virus (WNV) infection are
incompletely understood. During the summer and fall of
2003, we conducted a prospective, population-based study
among residents of a 3-county area in Colorado, United
States, with developing WNV-associated paralysis. Thirty-
two patients with developing paralysis and acute WNV
infection were identified. Causes included a poliomyelitis-
like syndrome in 27 (84%) patients and a Guillain-
Barré–like syndrome in 4 (13%); 1 had brachial plexus
involvement alone. The incidence of poliomyelitislike syn-
drome was 3.7/100,000. Twelve patients (38%), including 1
with Guillain-Barré–like syndrome, had acute respiratory
failure that required endotracheal intubation. At 4 months, 3
patients with respiratory failure died, 2 remained intubated,
25 showed various degrees of improvement, and 2 were
lost to followup. Apoliomyelitislike syndrome likely involving
spinal anterior horn cells is the most common mechanism
of WNV-associated paralysis and is associated with signif-
icant short- and long-term illness and death. 
A
cute paralysis associated with West Nile virus (WNV)
infection (1–8) has been attributed to Guillain-Barré
syndrome (3), a poliomyelitislike syndrome (2,4–6,8), and
a generalized myeloradiculitis (1,7). Several reports have
described acute respiratory failure occurring with WNV-
associated paralysis (5,7). However, the frequency of acute
paralysis in WNV neuroinvasive disease remains
unknown, and the clinical features of WNV-associated res-
piratory weakness have not been characterized.
During 2003, Colorado experienced an epidemic of
human WNV disease; 2,947 cases were reported to the US
Centers for Disease Control and Prevention (CDC) that
included 621 neuroinvasive cases and 63 deaths. Acute
paralysis was seen in many patients, and in several, acute
respiratory failure developed that required emergent intu-
bation. We conducted a population-based assessment of
WNV-infected persons in whom acute paralysis developed
to describe the clinical features, mechanisms, and short-
term outcomes.
Methods
During the summer and fall of 2003, we identified
patients with acute weakness and WNV infection from
among the populations of Boulder, Larimer, and Weld
counties (combined population ≈724,000) in northern
Colorado by active case-finding. We were notified of sus-
pected cases by infection control practitioners and health
professionals at 8 hospitals in and around the catchment
area and through ongoing state-based surveillance. A sus-
pected case of WNV-associated weakness was defined as
muscle weakness in a person of at least 1-point decrement
on manual muscle testing by using the Medical Research
Council (London, UK) 1–5 scale (see online Appendix
Figure 1, available at http://www.cdc.gov/ncidod/EID/
vol11no07/04-0991-appG1.htm), respiratory failure
requiring intubation that developed <48 hours after presen-
tation, or both. All patients had IgM antibodies detected in
acute-phase serum samples by IgM antibody-capture
enzyme-linked immunosorbent assay at the Colorado
Department of Health Services and Environment (9,10).
Remaining acute-phase serum samples from 26 patients
were tested by plaque-reduction neutralization assays for
antibodies to WNV and St. Louis encephalitis virus at
CDC (9,10). All had WNV-specific neutralizing antibody
titers ≥1:10, which were at least 4-fold greater than those
for St. Louis encephalitis virus.
Patients were approached under the auspices of a pub-
lic health event, and oral consent was obtained. Results of
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were obtained from patient interviews and medical
records. Results of serial neurologic examinations were
documented on a standardized form. 
Four months after initial assessment, we repeated the
neurologic examinations, and patients or family members
completed a self-administered questionnaire that gathered
information on functioning in daily activities. Strength
scores at 14 locations (see online Appendix Figure 2, avail-
able at http://www.cdc.gov/ncidod/EID/vol11no07/04-
0991-appG2.htm) were evaluated at nadir and followup by
using manual muscle testing scores. A proportional odds
model for the strength scores was used to evaluate
improvement; anticipated correlation was incorporated by
estimating model parameters with generalized estimating
equations. Within-patient correlations of the scores were
estimated, and all pairwise differences were evaluated for
significance by using bootstrap methods (11); adjustment
for multiple comparisons was made by using the
Bonferroni adjustment. Statistical analyses were per-
formed with SAS version 8.2 (SAS Institute, Cary, NC,
USA), S-Plus version 6.2 (Insightful Corp., Seattle, WA,
USA), Sudaan version 8.0.2 (Research Triangle Institute,
Research Triangle Park, NC, USA), and EpiInfo version
6.04d (CDC, Atlanta, GA, USA).
Results
Two hundred nineteen cases of WNV neuroinvasive
disease were identified by state-based surveillance in our
catchment area; among these, we identified 32 patients
with acute paralysis and WNV infection. Eighteen (56%)
were male; the median age was 56 years (range 15–84,
Figure 1). All but 1 were Caucasian, and 3 (9%) were
Hispanic. Sixteen patients (50%) had concomitant
encephalitis, 10 (31%) had meningitis, and 6 (19%) had
paralysis alone. Those 26 patients with concomitant
meningitis or encephalitis represented 12% of the patients
identified as having neuroinvasive disease. 
Twenty-nine patients were examined by study neurolo-
gists within 7 days of weakness onset; 2 patients were
evaluated on days 11 and 18 after weakness onset, respec-
tively, and initial neurologic findings for 1 patient were
obtained by personal communication (T. Clark, Colorado
Pulmonary Associates, Denver, CO, USA). All but 1 of the
patients were hospitalized. The median length of stay in
the hospital was 17 days (range 2–87 days). Five patients
(16%) with encephalitis were immunocompromised: 2 had
prior liver transplants, 2 had hematologic malignancies,
and 1 was receiving immunosuppressive medication for
rheumatoid arthritis. One patient had insulin-dependent
diabetes mellitus. Twenty-six (81%) had no prior medical
problems. 
Twenty-seven patients (84%) had asymmetric weak-
ness consistent with a poliomyelitislike syndrome, 4 (13%)
had symmetric ascending weakness with sensory abnor-
malities consistent with the acute inflammatory demyeli-
nating polyradiculoneuropathy form of Guillain-Barré
syndrome, and 1 had scapular winging and shoulder
abduction weakness consistent with a long thoracic nerve
paralysis.
Poliomyelitislike Syndrome
The incidence of poliomyelitislike syndrome was
3.7/100,000. Associated signs and symptoms are shown in
Table 1. Two patients had weakness in the absence of
other systemic features of infectious illness. Among 25
patients with systemic signs or symptoms listed in Table
1, including 4 in which weakness was concurrent with ill-
ness onset, the median interval between illness onset and
weakness onset was 3 days (range 0–18). All but 1 patient
had other neurologic features suggestive of acute WNV
infection (Table 1). Patterns of weakness (Appendix
Figure 1) included acute monoplegia (weakness or paral-
ysis of 1 limb, n = 5); asymmetric upper (n = 1) or lower
(n = 5) extremity weakness; and generalized asymmetric
tetraplegia or quadriplegia (asymmetric weakness in ≥3
limbs, n = 16). Deep tendon reflexes in affected limbs
were diminished or absent. Nineteen patients (70%) with
poliomyelitislike syndrome had cranial nerve involve-
ment, which included unilateral (n = 2) or bilateral (n = 8)
facial paralysis, extraocular muscle weakness (n = 4), dys-
phagia (n = 13), dysarthria (n = 6), and vocal cord paraly-
sis (n = 2). Limb weakness by strength testing or
subjective patient interpretation progressed to its lowest
point (nadir) within 24 hours in 24 patients (88%), with a
range of <6 hours to 3 days. Two patients reported senso-
ry deficits (subjective numbness or paresthesias), and 16
(60%) reported pain in affected limbs preceding onset of
weakness. Paralysis due to WNV infection in 2 patients
occurred exclusively in limbs with prior lower motor neu-
ron dysfunction due to lumbar disc herniation (previously
resolved with discectomy).
Electromyography/nerve conduction studies performed
on 14 patients with poliomyelitislike syndrome suggested
a motor axonopathy and/or an anterior horn cell process.
Preservation of voluntary motor unit potentials was
observed in all tested myotomes in 10 patients, and volun-
tary motor unit potentials were absent in some myotomes
in 4 patients. Fourteen patients with poliomyelitislike syn-
drome underwent magnetic resonance imaging (MRI) of
the brain (n = 6), spine (n = 2), or both (n = 6). Two dis-
played focal lesions of the basal ganglia, thalami, and
brainstem bilaterally on T2- and diffusion-weighted
sequences, and 4 (including 3 who did not undergo elec-
tromyography/nerve conduction studies) had signal abnor-
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diffusion-weighted sequences, suggesting anterior horn
cell involvement (Figure 2).  
Guillain-Barré–like Syndrome
Four patients had symmetric, ascending weakness with
sensory symptoms suggestive of the acute inflammatory
demyelinating polyradiculoneuropathy form of Guillain-
Barré syndrome (Appendix Figure 1). All 4 had symptoms
listed in Table 1 before weakness onset (range 2–12 days),
2 had meningitis before onset of weakness, and 2 had
tremors. Initial deep tendon flexes were diminished or
absent in all patients. Pain in affected limbs preceded
weakness in 2 patients. The median interval between
weakness onset and nadir was longer in patients with
Guillain-Barré–like syndrome (4 days) than those with
poliomyelitislike syndrome (1 day) (p<0.005, Wilcoxon
rank sum test). One patient with Guillain-Barré–like syn-
drome had facial diplegia. 
Electromyography/nerve conduction studies were car-
ried out in 3 patients with Guillain-Barré–like syndrome,
and all showed findings consistent with a predominantly
demyelinating sensorimotor neuropathy. In patients with
Guillain-Barré–like syndrome, voluntary motor unit poten-
tials were preserved in tested myotomes.
Brachial Plexus Neuropathy
One patient with meningitis exhibited apparent, isolat-
ed, long thoracic nerve weakness with scapular winging
and shoulder abduction weakness but without additional
limb involvement. This patient also had pain before onset
of weakness.
Respiratory Involvement 
Twelve patients (39%), including 1 patient with
Guillain-Barré–like syndrome, developed acute respiratory
weakness that required endotracheal intubation and eventu-
al tracheostomy (Table 2). In 10 patients, diaphragmatic
paralysis, shown by hemidiaphragmatic elevation on chest
radiograph, or pulmonary function test results with a
restrictive pattern and retention of carbon dioxide, suggest-
ed neuromuscular respiratory failure. These studies were
not available for the remaining 2 patients. Five additional
patients with poliomyelitislike syndrome had dyspnea and
showed evidence of diaphragmatic weakness by chest radi-
ograph and pulmonary function test results, but were not
intubated. Three patients died of respiratory failure 7, 27,
and 35 days after intubation, after ventilatory support was
withdrawn. All patients except the one with Guillain-
Barré–like syndrome had encephalitis. Patients in whom
dysarthria, dysphagia, or both developed were more likely
to experience subsequent respiratory failure (odds ratio
[OR] 62, p<0.0001, Fisher exact test). The interval between
onset of these bulbar symptoms and intubation was <1 day
in 9 of 12 patients (range <1–6 days). Facial nerve paraly-
sis without other cranial nerve abnormalities was not asso-
ciated with subsequent respiratory failure (Table 2).
Immunocompromised patients and patients with
encephalitis were more likely to experience respiratory
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Figure 1. Age distribution of 32 patients with West Nile virus–
associated paralysis.failure (Table 2). Pattern of limb weakness was not predic-
tive of respiratory failure; 3 patients had initial upper
extremity involvement, 4 had initial lower extremity
involvement, and 5 had more diffuse generalized involve-
ment before respiratory failure. 
Cerebrospinal Fluid (CSF) Parameters
Lumbar puncture was performed on 30 patients. They
had a median CSF leukocyte count of 108 cells/mm3
(range 0–740 cells/mm3), a median CSF protein level of 98
mg/dL (range 27–138 mg/dL), and a median CSF glucose
level of 55 mg/dL (range 36–135 mg/dL). Pleocytosis was
lymphocytic in 14 patients, neutrophilic in 13, and
unknown in 3. Among recorded cell differentials (n = 27),
neutrophils were predominant in CSF collected on or
before the day of weakness onset (10/14, 71%). CSF col-
lected after the time of weakness onset was more often
lymphocytic (10/13, 77%, OR 8.3, p = 0.03). Three of 4
patients with Guillain-Barré–like syndrome had lumbar
punctures; 2 had cytoalbuminologic dissociation (elevated
protein levels without pleocytosis) commonly seen in
Guillain-Barré syndrome, and 1 had pleocytosis with an
elevated protein level. The median CSF leukocyte count
and protein level (64 cells/mm3 and 100 mg/dL, respec-
tively) in patients with respiratory failure were not signifi-
cantly different from those without respiratory failure (117
cells/mm3 and 96 mg/dL, each p = 0.5, Wilcoxon rank sum
test). 
Short-term Outcomes
Three patients with poliomyelitislike syndrome died in
the hospital after withdrawal of ventilatory support. Of the
surviving patients, 13 were discharged and 15 (including 1
with Guillain-Barré–like syndrome) were admitted to
long-term care facilities. The patient with long thoracic
nerve palsy was not hospitalized. At 4 months, 2 patients
with poliomyelitislike syndrome were lost to followup. Of
15 patients sent to long-term care facilities, 5 with
poliomyelitislike syndrome and 1 with Guillain-Barré–like
syndrome remained in these facilities, and the remaining 9
had been discharged (median length of stay 40 days, range
17–106). No persons initially discharged were readmitted.
Of 21 patients employed or in school before illness, 9 were
working full-time or part-time at the 4-month followup.
Seventeen required continuing physical therapy.
Four of the 27 reassessed patients (patients 4, 18, 20,
and 43), all with poliomyelitislike syndrome, showed
almost no improvement in strength of involved muscles.
Two patients with Guillain-Barré–like syndrome regained
baseline strength. Although the remainder showed general
improvement by the proportional odds model (p<0.001),
none had returned to baseline status (Appendix Figure 1).
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Figure 2. Saggital (A) and axial (B)
T2-weighted magnetic resonance
images of the cervical spinal cord in a
patient with acute asymmetric upper
extremity weakness and subjective
dyspnea. A shows a diffuse cervical
cord signal abnormality, and B shows
an abnormal signal in the anterior
horn region.In patients with poliomyelitislike syndrome undergoing
electromyography studies, the absence of voluntary motor
unit potentials was associated with lack of strength
improvement in involved myotomes. Neurologic signs at 4
months are shown in Table 1. Three patients (all with res-
piratory paralysis) were nonambulatory; 12 of 24 ambula-
tory patients, including 2 with Guillain-Barré–like
syndrome, required a wheelchair (n = 4), walker (n = 3), or
canes or crutches (n = 5). 
Pairwise comparisons of the correlations among
patients with poliomyelitislike syndrome showed that at
both times, weakness was more likely to be of greater
severity in comparable limbs across the body (e.g., both
arms, both legs) than in limbs on the same side (e.g., right
arm and leg); facial weakness was strongly correlated with
ipsilateral arm weakness (Appendix Figure 2). Limbs
improved distally to a greater extent than proximally. 
Of 9 surviving patients who had respiratory failure, 2
remained intubated at 4 months, and 7 displayed various
degrees of improvement (Appendix Figure 1); however,
none had returned to baseline strength or level of function.
The median duration of intubation for the 7 extubated
patients was 49 days (mean 66 days, range 21–135). 
Discussion
The overall incidence of WNV-associated paralysis in
this population was 4.3/100,000, with an incidence of
poliomyelitislike syndrome of 3.7/100,000, which is com-
parable to that of paralysis seen during epidemics of
poliovirus disease (12). During 2003, 219 cases of neu-
roinvasive disease were reported in this 3-county area of
Colorado (13), of whom we estimate that flaccid paralysis
developed in 12%. Atotal of 2,773 cases of WNV neuroin-
vasive disease were reported in the United States during
the 2003 epidemic (13); ≈330 cases of WNV-associated
neuromuscular weakness may have occurred in the United
States during this period. 
In contrast to persons typically considered at risk for
WNV encephalitis alone, our patients were relatively
young, with a third-quartile age of 61 years (Figure 1), and
healthy, with >80% having no prior medical conditions.
Many patients required prolonged hospitalization and time
in rehabilitation facilities and had severe disabilities,
which suggests that paralysis caused by WNV infection is
associated with considerable lost productivity and incurred
healthcare costs. Thus, the long-term economic impact of
WNV paralysis needs assessment.
Twenty-seven patients with WNV-associated paralysis
had electrophysiologic or neuroimaging evidence of a
poliomyelitislike syndrome or a clinical syndrome com-
patible with this diagnosis. These patients had asymmetric,
acute weakness, pleocytosis, and in 14 patients with stud-
ies performed, results of electromyography/nerve conduc-
tion studies were consistent with motor axonopathy, ante-
rior horn cell involvement, or both. However, 4 patients
had clinical, electrophysiologic, and laboratory findings
more suggestive of a Guillain-Barré–like syndrome. These
patients had characteristic bilateral, symmetric, ascending
weakness with associated sensory symptoms, and 2 of 3
patients with available CSF data showed characteristic
cytoalbuminologic dissociation. The 3 patients who under-
went electrodiagnostic studies had findings consistent with
a demyelinating sensorimotor neuropathy typical of
Guillain-Barré–like syndrome (3,14). Further electrophys-
iologic and pathologic characterization of this syndrome is
needed because its management may differ from that of
poliomyelitis. 
Although WNV-associated weakness may occur with-
out other findings suggesting acute WNV disease (14), all
but 6 of our patients had meningitis or encephalitis and dis-
played other WNV-associated neurologic signs, including
tremors, myoclonus, and parkinsonism (15–18). A neu-
trophilic, rather than the more typical lymphocytic, pleo-
cytosis may be seen soon after onset of WNV disease (17)
or other viral infections of the central nervous system
(19–21). Our patients who had CSF obtained on the day of
or shortly after weakness onset were more likely to have a
neutrophilic pleocytosis than those with CSF obtained
later in their illness. Clinicians should recognize the poten-
tial for a neutrophilic predominance in CSF obtained early
in the course of WNV neuroinvasive disease. 
A generalized asymmetric tetraplegia or quadriplegia
was the most common weakness pattern, followed by
monoplegia. Consistent with previous reports (22), all
patients except 2 with Guillain-Barré–like syndrome
demonstrated continued weakness at 4 months, although
nearly all had some improvement in strength as indicated
by manual muscle testing scores. All 10 patients with a
poliomyelitislike illness who had even minimal preserva-
tion of motor unit potentials on initial electromyogram
improved in strength in associated myotomes at 4 months;
4 patients with no motor unit potentials on initial elec-
tromyogram did not improve in strength in these
myotomes. Complete destruction of large spinal motor
neurons correlating with a completely paralyzed muscle
has been observed in poliovirus-associated paralysis (23).
Absence of motor unit potentials on electromyography
may reflect this loss and may have prognostic value for
future strength recovery. However, independent predictors
of strength outcome remain unknown. 
The facial weakness observed in 40% of patients with
poliomyelitislike syndrome and in 1 patient with Guillain-
Barré–like syndrome nearly or completely resolved, which
is consistent with observations of patients with poliovirus
disease and suggests a favorable outcome of this manifes-
tation (24,25). Weakness was more severe in congruent
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weakness was associated more strongly with arm than with
leg weakness, which is consistent with the patchy focal
cell destruction demonstrated pathologically in WNV
poliomyelitis (26). Improvement in limb strength tended to
occur distally to proximally. 
Thirty-eight percent of the patients, including all 3 who
died, had respiratory failure requiring intubation, and 16%
of the patients had dyspnea and diagnostic evidence of
neuromuscular respiratory failure but were not intubated.
Respiratory failure has been described with WNV-associ-
ated paralysis (6–8) but has not been characterized in
detail. In 1 patient with Guillain-Barré–like syndrome, res-
piratory failure developed, a common complication of this
syndrome (27). However, the association with limb weak-
ness of a motor neuron or anterior horn cell type, presence
of an elevated hemidiaphragm on chest radiograph, and a
restrictive pattern of respiratory failure by pulmonary
function testing suggest a central, poliomyelitislike etiolo-
gy for respiratory failure in all other patients. This etiolo-
gy is supported by the electrodiagnostic findings of lower
motor neuron involvement in affected limbs in 5 patients
with respiratory failure. Additionally, histopathologic find-
ings in patients with respiratory weakness and WNV infec-
tion have demonstrated neuronophagia and leukocytic
inflammation of the dorsal motor nuclei of the vagus and
glossopharyngeal nerves, which is similar to that seen in
the spinal anterior horns (26). Disease due to poliovirus
infection has been associated with diaphragmatic, inter-
costal muscle, and bulbar weakness with respiratory fail-
ure (28–31), and poliomyelitislike respiratory
insufficiency has been described in infections with other
flaviviruses (32). 
Lower bulbar dysfunction, specifically dysarthria and
dysphagia, was more frequent in patients with respiratory
failure; in most, lower bulbar dysfunction followed or was
concurrent with limb weakness and preceded respiratory
failure by less than a day. Patients with lower bulbar signs
and acute limb paralysis require monitoring for respiratory
failure. Facial paralysis was not associated with increased
risk of respiratory failure, which possibly reflects the
neuroanatomic separation of the involved cranial nerve
nuclei. Although results of MRI are frequently reported as
normal in patients with WNV neuroinvasive disease,
detailed images of brainstem and cervical spine are fre-
quently not obtained. Although 4 patients displayed spinal
cord and ventral root lesions at involved levels, and 1
patient with respiratory failure had lower brainstem signal
abnormalities, detailed brainstem and spinal cord images
in our patients were generally not obtained. In patients
with acute weakness and bulbar signs, MRI should include
the lower brainstem and spinal cord. Although 2 patients
remained intubated at 4 months, all other surviving
patients with respiratory involvement were extubated,
although duration of ventilatory support was often pro-
longed. 
In summary, our findings suggest that involvement of
WNV with anterior horn cells, which resulted in a
poliomyelitislike syndrome, represents the most common
underlying cause of paralysis with WNV infection. In the
population assessed by our study, the incidence of paraly-
sis was comparable to that seen during large epidemics of
poliovirus infection. Respiratory involvement was a fre-
quent and severe manifestation of this syndrome, with a
high degree of illness and death. Thus, early and prominent
dysarthria and dysphagia may be predictors of subsequent
respiratory failure in this group. 
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